← Back to Search

ICARE Treatment for Traumatic Brain Injury (ICARE Trial)

N/A
Recruiting
Led By Flora Hammond, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-test 1), week 7, week 14, week 26, week 38
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a remote rehab program called ICARE to help people with brain injuries and their caregivers improve emotional understanding and relationships. It aims to teach them how to better recognize and respond to emotions, enhancing their relationship quality and emotional well-being.

Who is the study for?
This trial is for U.S. residents over 18 years old who are at least one year post-traumatic brain injury (TBI) and have difficulties with emotion recognition or empathy that they believe started after TBI. Participants must speak English, be able to follow directions, and have a care partner willing to join the study. They need internet access for video calls but can't be from California or have other neurological conditions affecting emotions.
What is being tested?
The ICARE Treatment program is being tested in this trial. It's a TeleRehab intervention designed to help people with TBI improve their ability to recognize and respond to others' emotions using video conferencing technology alongside their care partners.
What are the potential side effects?
Since ICARE Treatment involves therapy sessions rather than medication, typical drug side effects aren't expected. However, participants may experience emotional discomfort or fatigue during the exercises aimed at improving affect recognition and empathy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-test 1), week 7, week 14, week 26, week 38
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-test 1), week 7, week 14, week 26, week 38 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in St. Andrew's Swansea Neurobehavioral Outcome Scale-Interpersonal Behavior (SASNOS-IB)
Secondary study objectives
Change in Advanced Clinical Solutions- Social Perception- Facial Affect Naming subscale (ACS-SP-FAN)
Change in Brock Adaptive Functioning Questionnaire, empathy subscale (BAFQ-E)
Change in Daily Empathic Behavior Survey (DEBS)
+10 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment (ICARE)Experimental Treatment1 Intervention
ICARE treatment consisting of 12 sessions that train affect recognition and empathic behaviors.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Traumatic Brain Injury (TBI) include cognitive-behavioral therapy (CBT), physical therapy, and remote rehabilitation programs like TeleRehab (ICARE). These treatments work by targeting different aspects of brain function and recovery. CBT helps patients by restructuring negative thought patterns and improving emotional regulation, which is crucial for managing the psychological impact of TBI. Physical therapy focuses on restoring motor function and coordination through repetitive exercises that promote neuroplasticity. Remote rehabilitation programs, such as TeleRehab, leverage technology to provide consistent, accessible therapy aimed at improving cognitive functions like emotional recognition and response. These mechanisms are vital for TBI patients as they address both the physical and emotional challenges of recovery, ultimately enhancing their quality of life and functional independence.
The effectiveness of traumatic brain injury rehabilitation: a review.Delivering group treatment via videoconference to individuals with traumatic brain injury: a feasibility study.

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
1,040 Previous Clinical Trials
1,219,984 Total Patients Enrolled
Flora Hammond, MDPrincipal InvestigatorIndiana University
5 Previous Clinical Trials
329 Total Patients Enrolled
Dawn Neumann, Ph.D.Principal InvestigatorIndiana University

Media Library

ICARE Treatment Clinical Trial Eligibility Overview. Trial Name: NCT05636020 — N/A
Traumatic Brain Injury Research Study Groups: Treatment (ICARE)
Traumatic Brain Injury Clinical Trial 2023: ICARE Treatment Highlights & Side Effects. Trial Name: NCT05636020 — N/A
ICARE Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05636020 — N/A
~48 spots leftby Aug 2027